SU:EURONEXT PARISSchneider Electric SE Analysis
Data as of 2026-07-08 - not real-time
$56.66
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Suncor Energy is trading just above its short‑term moving average and comfortably below its longer‑term average, indicating a neutral price bias. The RSI sits in the mid‑range, while the MACD histogram has turned positive, giving a modest bullish signal. Valuation metrics show a price‑to‑earnings multiple well below the industry average and a discounted cash‑flow model that suggests a noticeable upside, positioning the stock as undervalued.
Fundamentally, the company delivers solid revenue growth, healthy margins and strong cash generation, supporting a sustainable dividend with a comfortable payout ratio. The balance sheet features moderate leverage and ample liquidity, while the beta is near zero, tempering market‑wide swings. Recent commentary highlights Suncor’s resilience amid oil‑price turbulence and its appeal to dividend‑focused investors, reinforcing the positive outlook.
Fundamentally, the company delivers solid revenue growth, healthy margins and strong cash generation, supporting a sustainable dividend with a comfortable payout ratio. The balance sheet features moderate leverage and ample liquidity, while the beta is near zero, tempering market‑wide swings. Recent commentary highlights Suncor’s resilience amid oil‑price turbulence and its appeal to dividend‑focused investors, reinforcing the positive outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Neutral technical trend with bullish MACD crossover
- Proximity to identified support level
- Elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to peers and DCF upside
- Strong cash flow and dividend yield
- Robust revenue growth and operating margins
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable dividend with low payout ratio
- Integrated business model providing diversification across the value chain
- Resilient fundamentals despite commodity cycle and regulatory transition
Key Metrics & Analysis
Financial Health
Revenue Growth17.50%
Profit Margin12.39%
P/E Ratio15.3
ROE13.97%
ROA5.95%
Debt/Equity32.36
P/B Ratio2.1
Op. Cash Flow$13.1B
Free Cash Flow$6.7B
Industry P/E20.7
Technical Analysis
TrendNeutral
RSI43.6
Support$53.29
Resistance$64.12
MA 20$57.12
MA 50$62.44
MA 200$53.02
MACDBullish
VolumeDecreasing
Fear & Greed Index88.07
Valuation
Fair Value$143.58
Target Price$62.89
Upside/Downside10.99%
GradeUndervalued
TypeBlend
Dividend Yield2.98%
Risk Assessment
Beta-0.10
Volatility32.83%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.